Federal contractors / LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award

75N91018F00066

IGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NCI
NAICS561210 — Facilities Support Services
PSCM1HA — OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES
Parent award / vehicleHHSN261201500003I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$14.8M
Current contract value$14.8M
Potential contract value / ceiling$26.7M
Start dateSep 30, 2018
Current end dateSep 29, 2023
Potential end dateSep 29, 2023
Latest award activityJun 18, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 18, 2026P00008$-3.2KFY26 UDO INITIATIVE
May 19, 2023P00007$0ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
Dec 22, 2021P00006$0ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
Jun 25, 2021P00005$0ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
May 24, 2021P00004$466.0KANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
May 26, 2020P00003$0ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
Sep 25, 2019P00002$5.9MANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
Dec 6, 2018P00001$1.0MIGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
Sep 26, 20180$7.4MIGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.